Cargando…

Clinical characterization and mitochondrial DNA sequence variations in Leber hereditary optic neuropathy

PURPOSE: Leber hereditary optic neuropathy (LHON), a maternally inherited disorder, results from point mutations in mitochondrial DNA (mtDNA). MtDNA is highly polymorphic in nature with very high mutation rate, 10–17 fold higher as compared to nuclear genome. Identification of new mtDNA sequence var...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Manoj, Kaur, Punit, Saxena, Rohit, Sharma, Pradeep, Dada, Rima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Vision 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501276/
https://www.ncbi.nlm.nih.gov/pubmed/23170061
_version_ 1782250171989491712
author Kumar, Manoj
Kaur, Punit
Kumar, Manoj
Saxena, Rohit
Sharma, Pradeep
Dada, Rima
author_facet Kumar, Manoj
Kaur, Punit
Kumar, Manoj
Saxena, Rohit
Sharma, Pradeep
Dada, Rima
author_sort Kumar, Manoj
collection PubMed
description PURPOSE: Leber hereditary optic neuropathy (LHON), a maternally inherited disorder, results from point mutations in mitochondrial DNA (mtDNA). MtDNA is highly polymorphic in nature with very high mutation rate, 10–17 fold higher as compared to nuclear genome. Identification of new mtDNA sequence variations is necessary to establish a clean link with human disease. Thus this study was aimed to assess or evaluate LHON patients for novel mtDNA sequence variations. MATERIALS AND METHODS: Twenty LHON patients were selected from the neuro-ophthalmology clinic of the All India Institute of Medical Sciences, New Delhi, India. DNA was isolated from whole blood samples. The entire coding region of the mitochondrial genome was amplified by PCR in 20 patients and 20 controls. For structural analysis (molecular modeling and simulation) the MODELER 9.2 program in Discovery Studio (DS 2.0) was used. RESULTS: MtDNA sequencing revealed a total of 47 nucleotide variations in the 20 LHON patients and 29 variations in 20 controls. Of 47 changes in patients 21.2% (10/47) were nonsynonymous and the remaining 78.72% (37/47) were synonymous. Five nonsynonymous changes, including primary LHON mutations (NADH dehydrogenase subunit 1 [ND1]:p.A52T, NADH dehydrogenase subunit 6 [ND6]:p.M64V, adenosine triphosphate [ATP] synthase subunit a (F-ATPase protein 6) [ATPase6]:p.M181T, NADH dehydrogenase subunit 4 [ND4]:p.R340H, and cytochrome B [CYB]:p.F181L), were found to be pathogenic. A greater number of changes were present in complex I (53.19%; 25/47), followed by complex III (19.14%; 9/47), then complex IV (19.14%; 9/47), then complex V (8.5%; 4/47). Nonsynonymous variations may impair respiratory chain and oxidative phosphorylation (OXPHOS) pathways, which results in low ATP production and elevated reactive oxygen species (ROS) levels. Oxidative stress is the underlying etiology in various diseases and also plays a crucial role in LHON. CONCLUSIONS: This study describes the role of mtDNA sequence variations in LHON patients. Primary LHON mutations of mtDNA are main variants leading to LHON, but mutations in other mitochondrial genes may also play an important role in pathogenesis of LHON as indicated in the present study. Certain alleles in certain haplogroups have protective or deleterious roles and hence there is a need to analyze a large number of cases for correlating phenotype and disease severity with mutation and mtDNA haplogroups.
format Online
Article
Text
id pubmed-3501276
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Molecular Vision
record_format MEDLINE/PubMed
spelling pubmed-35012762012-11-20 Clinical characterization and mitochondrial DNA sequence variations in Leber hereditary optic neuropathy Kumar, Manoj Kaur, Punit Kumar, Manoj Saxena, Rohit Sharma, Pradeep Dada, Rima Mol Vis Research Article PURPOSE: Leber hereditary optic neuropathy (LHON), a maternally inherited disorder, results from point mutations in mitochondrial DNA (mtDNA). MtDNA is highly polymorphic in nature with very high mutation rate, 10–17 fold higher as compared to nuclear genome. Identification of new mtDNA sequence variations is necessary to establish a clean link with human disease. Thus this study was aimed to assess or evaluate LHON patients for novel mtDNA sequence variations. MATERIALS AND METHODS: Twenty LHON patients were selected from the neuro-ophthalmology clinic of the All India Institute of Medical Sciences, New Delhi, India. DNA was isolated from whole blood samples. The entire coding region of the mitochondrial genome was amplified by PCR in 20 patients and 20 controls. For structural analysis (molecular modeling and simulation) the MODELER 9.2 program in Discovery Studio (DS 2.0) was used. RESULTS: MtDNA sequencing revealed a total of 47 nucleotide variations in the 20 LHON patients and 29 variations in 20 controls. Of 47 changes in patients 21.2% (10/47) were nonsynonymous and the remaining 78.72% (37/47) were synonymous. Five nonsynonymous changes, including primary LHON mutations (NADH dehydrogenase subunit 1 [ND1]:p.A52T, NADH dehydrogenase subunit 6 [ND6]:p.M64V, adenosine triphosphate [ATP] synthase subunit a (F-ATPase protein 6) [ATPase6]:p.M181T, NADH dehydrogenase subunit 4 [ND4]:p.R340H, and cytochrome B [CYB]:p.F181L), were found to be pathogenic. A greater number of changes were present in complex I (53.19%; 25/47), followed by complex III (19.14%; 9/47), then complex IV (19.14%; 9/47), then complex V (8.5%; 4/47). Nonsynonymous variations may impair respiratory chain and oxidative phosphorylation (OXPHOS) pathways, which results in low ATP production and elevated reactive oxygen species (ROS) levels. Oxidative stress is the underlying etiology in various diseases and also plays a crucial role in LHON. CONCLUSIONS: This study describes the role of mtDNA sequence variations in LHON patients. Primary LHON mutations of mtDNA are main variants leading to LHON, but mutations in other mitochondrial genes may also play an important role in pathogenesis of LHON as indicated in the present study. Certain alleles in certain haplogroups have protective or deleterious roles and hence there is a need to analyze a large number of cases for correlating phenotype and disease severity with mutation and mtDNA haplogroups. Molecular Vision 2012-11-12 /pmc/articles/PMC3501276/ /pubmed/23170061 Text en Copyright © 2012 Molecular Vision. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kumar, Manoj
Kaur, Punit
Kumar, Manoj
Saxena, Rohit
Sharma, Pradeep
Dada, Rima
Clinical characterization and mitochondrial DNA sequence variations in Leber hereditary optic neuropathy
title Clinical characterization and mitochondrial DNA sequence variations in Leber hereditary optic neuropathy
title_full Clinical characterization and mitochondrial DNA sequence variations in Leber hereditary optic neuropathy
title_fullStr Clinical characterization and mitochondrial DNA sequence variations in Leber hereditary optic neuropathy
title_full_unstemmed Clinical characterization and mitochondrial DNA sequence variations in Leber hereditary optic neuropathy
title_short Clinical characterization and mitochondrial DNA sequence variations in Leber hereditary optic neuropathy
title_sort clinical characterization and mitochondrial dna sequence variations in leber hereditary optic neuropathy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501276/
https://www.ncbi.nlm.nih.gov/pubmed/23170061
work_keys_str_mv AT kumarmanoj clinicalcharacterizationandmitochondrialdnasequencevariationsinleberhereditaryopticneuropathy
AT kaurpunit clinicalcharacterizationandmitochondrialdnasequencevariationsinleberhereditaryopticneuropathy
AT kumarmanoj clinicalcharacterizationandmitochondrialdnasequencevariationsinleberhereditaryopticneuropathy
AT saxenarohit clinicalcharacterizationandmitochondrialdnasequencevariationsinleberhereditaryopticneuropathy
AT sharmapradeep clinicalcharacterizationandmitochondrialdnasequencevariationsinleberhereditaryopticneuropathy
AT dadarima clinicalcharacterizationandmitochondrialdnasequencevariationsinleberhereditaryopticneuropathy